| dc.contributor.author | Asselah, T | en_US |
| dc.contributor.author | Moreno, C | en_US |
| dc.contributor.author | Sarrazin, C | en_US |
| dc.contributor.author | Gschwantler, M | en_US |
| dc.contributor.author | Foster, GR | en_US |
| dc.contributor.author | Craxi, A | en_US |
| dc.contributor.author | Buggisch, P | en_US |
| dc.contributor.author | Ryan, R | en_US |
| dc.contributor.author | Lenz, O | en_US |
| dc.contributor.author | Scott, J | en_US |
| dc.contributor.author | Van Dooren, G | en_US |
| dc.contributor.author | Lonjon-Domanec, I | en_US |
| dc.contributor.author | Schlag, M | en_US |
| dc.contributor.author | Buti, M | en_US |
| dc.date.accessioned | 2016-10-07T12:40:47Z | |
| dc.date.available | 2016-06-16 | en_US |
| dc.date.issued | 2016-07-18 | en_US |
| dc.date.submitted | 2016-09-27T12:53:13.130Z | |
| dc.identifier.issn | 1932-6203 | en_US |
| dc.identifier.other | ARTN e0158526 | en_US |
| dc.identifier.other | ARTN e0158526 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/15774 | |
| dc.description.sponsorship | The study described in this manuscript (HPC3014; NCT01846832) was sponsored by Janssen Pharmaceuticals. The funder was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Editorial support was provided by Ian Grieve (Medical Writer at Zoetic Science, an Ashfield Company, part of UDG Healthcare plc, Macclesfield, United Kingdom); this support was funded by Janssen Pharmaceuticals. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. | en_US |
| dc.relation.ispartof | PLOS ONE | en_US |
| dc.rights | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
| dc.title | An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1) | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2016 Asselah et al. | |
| dc.identifier.doi | 10.1371/journal.pone.0158526 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380169300011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 7 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 11 | en_US |
